SOURCE: ProPhase Labs, Inc.

ProPhase Labs, Inc.

February 27, 2015 07:15 ET

CEO & Chairman Ted William Karkus of ProPhase Labs, Inc. to Be Interviewed Live on Clear Channel - iHeart Business Talk Radio's "Health Tech Talk Live"

Live Interview Airs Saturday, February 28th, 2015, 3:00pm ET/12:00pm PT/2:00pm CT

DOYLESTOWN, PA--(Marketwired - Feb 27, 2015) - ProPhase Labs, Inc. (NASDAQ: PRPH), a company that engages in the manufacture, marketing, and distribution of homeopathic and health products to the general public, announced today that CEO & Chairman Ted William Karkus will be interviewed live on iHeart Radio's Health Tech Talk Live hosted by Ben Chodor and broadcasted nationwide on iHeart Radio/ Clear Channel Atlanta Studios - 640 WGST AM this Saturday at 3:00pm ET. In this exclusive 2-segment interview, Mr. Karkus will discuss the research and development of over-the-counter (OTC) drugs, natural base health products with supplements, personal care and cosmeceutical products. We encourage investors, analysts, industry professionals and all interested parties to tune in and listen live via Clear Channel's nationally syndicated iHeart Radio stream.

Date: February 28, 2015
Start Time: 3:00pm ET | 12:00pm PT | 2:00pm CT (U.S.)
Network: iHeart Radio/ Clear Channel
Station: 640 WGST AM
Show: Health Tech Talk Live
Host: Ben Chodor
iHeart Radio Live Stream: CLICK HERE

About ProPhase Labs, Inc.
ProPhase Labs is a diversified natural health medical science company. It is a leading marketer of the Cold-EEZE® Cold Remedy brand as well as other cold relief products. Cold-EEZE® Cold Remedy zinc gluconate lozenges are clinically proven to significantly reduce the duration of the common cold. Cold-EEZE® Cold Remedy customers include leading national retailers, chain food, drug and mass merchandise stores, wholesalers and distributors, as well as independent pharmacies. ProPhase Labs has several wholly owned subsidiaries including a manufacturing unit, which consists of an FDA registered facility to manufacture Cold-EEZE® Cold Remedy lozenges and fulfill other contract manufacturing opportunities. For more information visit us at www.ProPhaseLabs.com.

About iHeart Radio/ Clear Channel
Clear Channel's Media and Entertainment division has the largest reach of any radio or television outlet in America with 243 million monthly listeners. It serves 150 cities through 850 owned radio stations in the U.S., as well as more than 140 stations in New Zealand and Australia. For more Information Visit: http://www.iheart.com/live/talk-radio-640-wgst-6066/?autoplay=true&pname=15153&campid=play_bar&cid=main.html.

About HealthTech Talk Live
HealthTech Talk Live broadcasts live weekly on iHeart Radio / Clear Channel nationwide from 640 WGST AM Atlanta, 3:00pm - 4:00pm EST every Saturday. Host Ben Chodor interviews the front-page emerging health tech innovators and titans about the latest in digital health technology, human ingenuity, bio-tech medical advancements and health tech capital market trends. Learn how the experts use risk management techniques and clinical trials to build fully diversified portfolios and what it takes to put up big board earnings from making people healthier. It's a fast moving, high-energy show... shift your thinking and join us as we deliver "tomorrow's ideas today" on iHeart Radio and Clear Channel's HealthTech Talk Live. Visit iHeart Radio's HealthTech Talk Radio Show or visit www.HealthTechTalk.com.

If you're interested in being a guest on HealthTech Talk Live radio show, please contact 1800PublicRelations at support@1800pr.com "ATTN: Health Tech Talk Guest Inquiry."

Forward Looking Information
Except for the historical information contained herein or discussed on air on February 28, 2015, this document and our on-air discussion contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks and uncertainties, including the difficulty of the acceptance and demand for our products, the impact of competitive products and pricing, the timely development and launch of new products, and the risk factors listed from time to time in our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and any subsequent SEC filings.

Contact Information